China’s Five-Year Plan for Biotech Making it Increasingly Attractive for Global Pharma
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
CPA Economist Jeff Ferry’s Final Installment on the “America Way” of Growth
Jeff Ferry, CPA’s chief economist, takes a historical look at the early days of American industrial might, how it all went wrong through hyperglobalization, and where we must go from here.
CPA’s Chief Economist Jeff Ferry on the “American Way” of Economic Growth
Jeff Ferry pens a two-part series on the history of the American rise from new nation, to new industrial power. How it happened may surprise some.
Global Corporate Earnings Putting Overvalued Dollar in Spotlight
A look at what some senior executives are saying this earnings season about the dollar’s misalignment with the major currencies of the world.
Domestic Manufacturer’s Share of U.S. Market is Shrinking. CPA Economists Explain Why.
CPA economists Jeff Ferry and Amanda Mayoral explain the continued deterioration of market share for domestic producers versus imports.
China Commission Hears Testimony from Reshoring Advocate
A China Beige Book executive makes the case for reshoring in testimony to the U.S. China Economic and Security Review Commission. Meanwhile, U.S. manufacturers continue to lose local market share to imports.
June Trade Deficit Drops 6.2%, But 2022 Still Set for Highest Deficit Ever
Manufactured goods helped increase exports for June and lowered the trade deficit for the month. But on balance, the U.S. is careening towards another record-breaking year for the goods trade deficit.
How the Inflation Reduction Act Helps Fix Tax Discrimination Against Domestic Manufacturing
CPA tax policy director, David Morse, explains why mostly-domestic companies with over a billion in profits might get a more even playing field with rivals who use profit shifting, offshoring, to pay less taxes.
U.S. Solar Sector Gets Huge Relief in Inflation Reduction Act of 2022
Solar tax credits will make up for some of the damage done to the Section 201 solar safeguards. But Congress beware: the U.S. can’t out-subsidize China.
What the CHIPS Act Really Means for U.S. Semiconductor Manufacturers
CPA chief economist Jeff Ferry says the CHIPS Act is needed to counter China’s rise in the semiconductor space, and that the R&D component of the bill needs to include guardrails so American academia isn’t beta-testing and researching new chips in partnership with Chinese universities and companies.
